AU2373800A - Neuron-associated proteins - Google Patents

Neuron-associated proteins

Info

Publication number
AU2373800A
AU2373800A AU23738/00A AU2373800A AU2373800A AU 2373800 A AU2373800 A AU 2373800A AU 23738/00 A AU23738/00 A AU 23738/00A AU 2373800 A AU2373800 A AU 2373800A AU 2373800 A AU2373800 A AU 2373800A
Authority
AU
Australia
Prior art keywords
neuron
associated proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU23738/00A
Other languages
English (en)
Inventor
Janice Au-Young
Yalda Azimzai
Mariah R. Baughn
Jennifer L. Hillman
Preeti Lal
Dyung Aina M. Lu
Y. Tom Tang
Junming Yang
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU2373800A publication Critical patent/AU2373800A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Neurology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AU23738/00A 1998-12-11 1999-12-10 Neuron-associated proteins Abandoned AU2373800A (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US21008398A 1998-12-11 1998-12-11
US09210083 1998-12-11
US11936599P 1999-02-09 1999-02-09
US60119365 1999-02-09
US12468799P 1999-03-16 1999-03-16
US60124687 1999-03-16
PCT/US1999/030408 WO2000034477A2 (en) 1998-12-11 1999-12-10 Neuron-associated proteins
USNOTGIVEN 2000-11-08

Publications (1)

Publication Number Publication Date
AU2373800A true AU2373800A (en) 2000-06-26

Family

ID=27382298

Family Applications (1)

Application Number Title Priority Date Filing Date
AU23738/00A Abandoned AU2373800A (en) 1998-12-11 1999-12-10 Neuron-associated proteins

Country Status (5)

Country Link
EP (1) EP1135494A2 (ja)
JP (1) JP2003518913A (ja)
AU (1) AU2373800A (ja)
CA (1) CA2353797A1 (ja)
WO (1) WO2000034477A2 (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2050762A3 (en) * 1998-03-10 2009-07-08 Genentech, Inc. Human cornichon-like protein and nucleic acids encoding it
US7723488B2 (en) 1998-03-27 2010-05-25 Genentech, Inc. Monoclonal antibodies to secreted and transmembrane polypeptides
ATE348108T1 (de) * 1999-03-08 2007-01-15 Genentech Inc Methode zum nachweis von tumoren
US7129324B2 (en) * 1999-06-22 2006-10-31 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US20090176722A9 (en) 2000-01-28 2009-07-09 Shiv Srivastava Androgen-regulated PMEPA1 gene and polypeptides
JP2004506443A (ja) * 2000-08-22 2004-03-04 ブライハム　アンド　ウィメンズ　ホスピタル　インコーポレーテッド 心血管状態の診断および処置
US20030207801A1 (en) * 2000-10-23 2003-11-06 Valerie Gerlach Novel polypeptides and nucleic acids encoding same
JP4584573B2 (ja) * 2001-05-25 2010-11-24 ナイモックス コーポレーション 細胞の除去または破壊を必要とする腫瘍および他の状態の処置に有効なペプチド
EP1417227B1 (en) 2001-07-19 2007-01-10 Nymox Corporation Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells
EP1847550A3 (en) * 2001-07-19 2008-01-09 Nymox Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
US7317077B2 (en) * 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
EP2311468B1 (en) 2003-08-08 2014-01-15 Perseus Proteomics Inc. Gene overexpressed in cancer
EP1734998A2 (en) 2004-04-14 2006-12-27 Genentech, Inc. Compositions and methods comprising an egfl7 antagonist for modulating vascular development
WO2007130627A2 (en) 2006-05-04 2007-11-15 The Brigham And Women's Hospital, Inc. Il-33 in the treatment and diagnosis of diseases and disorders
TWI428142B (zh) 2009-05-08 2014-03-01 Genentech Inc 人類化之抗－ｅｇｆｌ７抗體及其使用方法
US11628202B2 (en) 2015-07-24 2023-04-18 Nymox Corporation Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia
US10183058B2 (en) 2016-06-17 2019-01-22 Nymox Corporation Method of preventing or reducing the progression of prostate cancer
US10172910B2 (en) 2016-07-28 2019-01-08 Nymox Corporation Method of preventing or reducing the incidence of acute urinary retention
US10532081B2 (en) 2016-09-07 2020-01-14 Nymox Corporation Method of ameliorating or preventing the worsening or the progression of symptoms of BPH
US10335453B2 (en) 2017-03-01 2019-07-02 Nymox Corporation Compositions and methods for improving sexual function
US20230241170A1 (en) * 2020-07-10 2023-08-03 Ohio State Innovation Foundation Epidermal growth factor-like 7 peptide and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1367124A1 (en) * 1997-08-01 2003-12-03 Genset 5' ests for secreted proteins expressed in muscle and other mesodermal tissues

Also Published As

Publication number Publication date
WO2000034477A3 (en) 2000-11-09
JP2003518913A (ja) 2003-06-17
WO2000034477A2 (en) 2000-06-15
CA2353797A1 (en) 2000-06-15
EP1135494A2 (en) 2001-09-26

Similar Documents

Publication Publication Date Title
AU2434199A (en) Protein
AU3562299A (en) Inhibin-hbc fusion protein
AU2373800A (en) Neuron-associated proteins
AU6045900A (en) Interaction-activated proteins
AU4281999A (en) Peptide
AU1744900A (en) Gtpase associated proteins
AU4930399A (en) Novel Polypeptide
AU4081000A (en) Uncoupling proteins
AU6000698A (en) Proteins
AU1881200A (en) Novel proteins
AU4857999A (en) Neurotransmission associated proteins
AU6983000A (en) Chimeric proteins
AU1540701A (en) Novel protein
AU1552800A (en) Coupled peptides
AU1184800A (en) Novel polypeptide
AU2390800A (en) Secreted proteins
AU2002500A (en) Novel protein
AU7304600A (en) Novel protein
AU4438599A (en) Human arf-related proteins
AUPP460498A0 (en) Modified proteins
AU4791099A (en) Protein secretion
AU6444600A (en) New protein
AU4440899A (en) Dap-kinase related protein
AU2658099A (en) Caf1-related protein
AU6289999A (en) Follistatin-related protein zfsta2

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase